Point prevalence surveys of antimicrobial use among eight neonatal intensive care units in India: 2016
Background: Information about antimicrobial use is scarce and poorly understood among neonatal intensive care units (NICUs) in India. In this study, we describe antimicrobial use in eight NICUs using four point prevalence surveys (PPSs). Methods: As part of the Global Antimicrobial Resistance, Presc...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-06-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971218300766 |
id |
doaj-0a4c8fffcc3e41a1b1d318db9a8bcdd4 |
---|---|
record_format |
Article |
spelling |
doaj-0a4c8fffcc3e41a1b1d318db9a8bcdd42020-11-24T21:56:50ZengElsevierInternational Journal of Infectious Diseases1201-97121878-35112018-06-0171C202410.1016/j.ijid.2018.03.017Point prevalence surveys of antimicrobial use among eight neonatal intensive care units in India: 2016Sumanth Gandra0Gerardo Alvarez-Uria1Srinivas Murki2Sanjeev K. Singh3Ravishankar Kanithi4Dasaratha R. Jinka5Ashok K. Chikkappa6Sreeram Subramanian7Anita Sharma8Dhanya Dharmapalan9Hemasree Kandraju10Anil Kumar Vasudevan11Onkaraiah Tunga12Akhila Akula13Yingfen Hsia14Mike Sharland15Ramanan Laxminarayan16Center for Disease Dynamics, Economics & Policy, New Delhi, IndiaRural Development Trust Hospital, Bathalapalli, Andhra Pradesh, IndiaFernandez Hospital, Hyderabad, Telangana, IndiaAmrita Institute of Medical Sciences, Kochi, Kerala, IndiaSowmya Children’s Hospital, Hyderabad, Telangana, IndiaRural Development Trust Hospital, Bathalapalli, Andhra Pradesh, IndiaRural Development Trust Hospital, Kalyanadurgam, Andhra Pradesh, IndiaParamitha Children’s Hospital, Hyderabad, Telangana, IndiaFortis Hospital, Mohali, Punjab, IndiaYewale Hospital, Mumbai, Maharashtra, IndiaFernandez Hospital, Hyderabad, Telangana, IndiaAmrita Institute of Medical Sciences, Kochi, Kerala, IndiaRural Development Trust Hospital, Kalyanadurgam, Andhra Pradesh, IndiaSowmya Children’s Hospital, Hyderabad, Telangana, IndiaSt. Georges University, London, United KingdomSt. Georges University, London, United KingdomCenter for Disease Dynamics, Economics & Policy, New Delhi, IndiaBackground: Information about antimicrobial use is scarce and poorly understood among neonatal intensive care units (NICUs) in India. In this study, we describe antimicrobial use in eight NICUs using four point prevalence surveys (PPSs). Methods: As part of the Global Antimicrobial Resistance, Prescribing, and Efficacy in Neonates and Children (GARPEC) study, one-day, cross-sectional, hospital-based PPSs were conducted four times between 1 February 2016 and 28 February 2017 in eight NICUs. Using a standardized web-based electronic data entry form, detailed data were collected for babies on antimicrobials. Results: A total of 403 babies were admitted to NICUs across all survey days, and 208 (51.6%) were prescribed one or more antimicrobials. Among 208 babies, 155 (74.5%) were prescribed antimicrobials for treatment of an active infection. Among 155 babies with an active infection, treatment was empiric in 109 (70.3%). Sepsis (108, 49.1%) was the most common reason for prescribing antimicrobials. Amikacin (17%) followed by meropenem (12%) were the two most commonly prescribed antimicrobials. For community-acquired sepsis, piperacillin-tazobactam (17.5%) was the most commonly prescribed drug. A combination of ampicillin and gentamicin was prescribed in only two babies (5%). Conclusions: The recommended first-line antimicrobial agents, ampicillin and gentamicin, were rarely prescribed in Indian NICUs for community acquired neonatal sepsis.http://www.sciencedirect.com/science/article/pii/S1201971218300766Point prevalence surveyAntimicrobial useNeonatesNICUIndia |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sumanth Gandra Gerardo Alvarez-Uria Srinivas Murki Sanjeev K. Singh Ravishankar Kanithi Dasaratha R. Jinka Ashok K. Chikkappa Sreeram Subramanian Anita Sharma Dhanya Dharmapalan Hemasree Kandraju Anil Kumar Vasudevan Onkaraiah Tunga Akhila Akula Yingfen Hsia Mike Sharland Ramanan Laxminarayan |
spellingShingle |
Sumanth Gandra Gerardo Alvarez-Uria Srinivas Murki Sanjeev K. Singh Ravishankar Kanithi Dasaratha R. Jinka Ashok K. Chikkappa Sreeram Subramanian Anita Sharma Dhanya Dharmapalan Hemasree Kandraju Anil Kumar Vasudevan Onkaraiah Tunga Akhila Akula Yingfen Hsia Mike Sharland Ramanan Laxminarayan Point prevalence surveys of antimicrobial use among eight neonatal intensive care units in India: 2016 International Journal of Infectious Diseases Point prevalence survey Antimicrobial use Neonates NICU India |
author_facet |
Sumanth Gandra Gerardo Alvarez-Uria Srinivas Murki Sanjeev K. Singh Ravishankar Kanithi Dasaratha R. Jinka Ashok K. Chikkappa Sreeram Subramanian Anita Sharma Dhanya Dharmapalan Hemasree Kandraju Anil Kumar Vasudevan Onkaraiah Tunga Akhila Akula Yingfen Hsia Mike Sharland Ramanan Laxminarayan |
author_sort |
Sumanth Gandra |
title |
Point prevalence surveys of antimicrobial use among eight neonatal intensive care units in India: 2016 |
title_short |
Point prevalence surveys of antimicrobial use among eight neonatal intensive care units in India: 2016 |
title_full |
Point prevalence surveys of antimicrobial use among eight neonatal intensive care units in India: 2016 |
title_fullStr |
Point prevalence surveys of antimicrobial use among eight neonatal intensive care units in India: 2016 |
title_full_unstemmed |
Point prevalence surveys of antimicrobial use among eight neonatal intensive care units in India: 2016 |
title_sort |
point prevalence surveys of antimicrobial use among eight neonatal intensive care units in india: 2016 |
publisher |
Elsevier |
series |
International Journal of Infectious Diseases |
issn |
1201-9712 1878-3511 |
publishDate |
2018-06-01 |
description |
Background: Information about antimicrobial use is scarce and poorly understood among neonatal intensive care units (NICUs) in India. In this study, we describe antimicrobial use in eight NICUs using four point prevalence surveys (PPSs).
Methods: As part of the Global Antimicrobial Resistance, Prescribing, and Efficacy in Neonates and Children (GARPEC) study, one-day, cross-sectional, hospital-based PPSs were conducted four times between 1 February 2016 and 28 February 2017 in eight NICUs. Using a standardized web-based electronic data entry form, detailed data were collected for babies on antimicrobials.
Results: A total of 403 babies were admitted to NICUs across all survey days, and 208 (51.6%) were prescribed one or more antimicrobials. Among 208 babies, 155 (74.5%) were prescribed antimicrobials for treatment of an active infection. Among 155 babies with an active infection, treatment was empiric in 109 (70.3%). Sepsis (108, 49.1%) was the most common reason for prescribing antimicrobials. Amikacin (17%) followed by meropenem (12%) were the two most commonly prescribed antimicrobials. For community-acquired sepsis, piperacillin-tazobactam (17.5%) was the most commonly prescribed drug. A combination of ampicillin and gentamicin was prescribed in only two babies (5%).
Conclusions: The recommended first-line antimicrobial agents, ampicillin and gentamicin, were rarely prescribed in Indian NICUs for community acquired neonatal sepsis. |
topic |
Point prevalence survey Antimicrobial use Neonates NICU India |
url |
http://www.sciencedirect.com/science/article/pii/S1201971218300766 |
work_keys_str_mv |
AT sumanthgandra pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016 AT gerardoalvarezuria pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016 AT srinivasmurki pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016 AT sanjeevksingh pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016 AT ravishankarkanithi pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016 AT dasaratharjinka pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016 AT ashokkchikkappa pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016 AT sreeramsubramanian pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016 AT anitasharma pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016 AT dhanyadharmapalan pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016 AT hemasreekandraju pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016 AT anilkumarvasudevan pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016 AT onkaraiahtunga pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016 AT akhilaakula pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016 AT yingfenhsia pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016 AT mikesharland pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016 AT ramananlaxminarayan pointprevalencesurveysofantimicrobialuseamongeightneonatalintensivecareunitsinindia2016 |
_version_ |
1725856864294404096 |